{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-102324","form_type":"8-K","ticker":"OGN","cik":"0001821825","company_name":"Organon & Co.","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.619067+00:00","generated_at":"2026-05-17T02:12:47.678244+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Organon CEO resigns after probe finds improper Nexplanon wholesaler sales; Morrissey named interim CEO","bullets":["Kevin Ali resigned as CEO and Board member; no severance or equity retirement benefits.","Audit Committee investigation found wholesalers asked to buy excess Nexplanon in 7 quarters; sales <1% of annual revenue but helped meet guidance.","Joseph Morrissey appointed Interim CEO; salary raised to $1M, bonus target 100%, LTI target $4M, one-time RSU grant of $1M.","Carrie Cox named Executive Chair; Robert Essner Lead Independent Director; Helene Gayle chairs Talent Committee.","No restatement of prior financials; 2024 internal control opinion withdrawn; Head of US Commercial & Government Affairs terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-102324","json":"https://secwatch.observer/filing/0001104659-25-102324.json","markdown":"https://secwatch.observer/filing/0001104659-25-102324.md","text":"https://secwatch.observer/filing/0001104659-25-102324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821825/000110465925102324/0001104659-25-102324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821825/000110465925102324/tm2529513d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:12:47.678244+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}